The Pennant Group (NASDAQ:PNTG) Issues FY 2025 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.140-1.180 for the period, compared to the consensus earnings per share estimate of 1.060. The company issued revenue guidance of $911.4 million-$948.6 million, compared to the consensus revenue estimate of $909.3 million.

Wall Street Analysts Forecast Growth

PNTG has been the subject of a number of research reports. Wells Fargo & Company decreased their price objective on The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Truist Financial cut their price objective on shares of The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Stephens reaffirmed an “overweight” rating and set a $40.00 target price on shares of The Pennant Group in a research note on Thursday, October 9th. Wall Street Zen lowered The Pennant Group from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of The Pennant Group in a research report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, The Pennant Group presently has an average rating of “Moderate Buy” and a consensus price target of $32.80.

The Pennant Group Stock Performance

Shares of NASDAQ PNTG traded up $1.79 during trading on Friday, reaching $25.54. 491,421 shares of the company traded hands, compared to its average volume of 264,890. The firm has a 50 day simple moving average of $24.74 and a 200-day simple moving average of $25.81. The Pennant Group has a 52-week low of $21.18 and a 52-week high of $34.27. The stock has a market capitalization of $882.66 million, a PE ratio of 34.05, a P/E/G ratio of 2.07 and a beta of 1.39. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.11.

The Pennant Group (NASDAQ:PNTG) last issued its earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.01. The company had revenue of $229.04 million for the quarter, compared to analysts’ expectations of $221.96 million. The Pennant Group had a net margin of 3.15% and a return on equity of 9.52%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. Equities research analysts anticipate that The Pennant Group will post 0.75 earnings per share for the current year.

Institutional Investors Weigh In On The Pennant Group

A number of hedge funds have recently modified their holdings of PNTG. Ameriprise Financial Inc. purchased a new stake in shares of The Pennant Group in the 2nd quarter worth $14,356,000. Kent Lake PR LLC grew its holdings in The Pennant Group by 16.3% during the second quarter. Kent Lake PR LLC now owns 465,100 shares of the company’s stock valued at $13,883,000 after purchasing an additional 65,100 shares during the period. Bank of America Corp DE increased its position in The Pennant Group by 14.3% in the second quarter. Bank of America Corp DE now owns 160,601 shares of the company’s stock worth $4,794,000 after buying an additional 20,034 shares in the last quarter. Invesco Ltd. raised its stake in shares of The Pennant Group by 168.8% in the second quarter. Invesco Ltd. now owns 131,578 shares of the company’s stock worth $3,928,000 after buying an additional 82,633 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of The Pennant Group by 288.4% in the third quarter. JPMorgan Chase & Co. now owns 130,721 shares of the company’s stock worth $3,297,000 after buying an additional 97,061 shares during the period. Institutional investors own 85.88% of the company’s stock.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.